Reference: 209 Title: Global and U.S. prevalence of metabolic (non-alcoholic) fatty liver disease Summary: As of 2017, metabolic dysfunction-associated fatty liver disease affected 25%–30% of adults worldwide, including 75–100 million Americans. URL: https://en.wikipedia.org/wiki/Metabolic_dysfunction%E2%80%93associated_steatotic_liver_disease